Rocket Pharmaceuticals (RCKT) Other Working Capital Changes (2022 - 2023)
Rocket Pharmaceuticals (RCKT) posted Other Working Capital Changes of $1.6 million for Q1 2026, up 242.87% sequentially from -$1.2 million in Q4 2025, and up 251.82% YoY from $467000.0 in Q1 2025.
Rocket Pharmaceuticals (RCKT) Other Working Capital Changes (2022 - 2023) Analysis & Trends
Rocket Pharmaceuticals has reported Other Working Capital Changes for 2 years, with the latest figure at $18000.0 in Q3 2023.
- Quarterly Other Working Capital Changes rose 251.82% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$913000.0 (down 3869.57% YoY) and the FY2025 annual result came in at -$2.1 million, down 416.04% from the prior year.
- Other Working Capital Changes rose to $1.6 million in Q1 2026 per RCKT's latest filing, from -$1.2 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $4.7 million in Q3 2023 and troughed at -$4.7 million in Q4 2023.
- A 5-year average of $65529.4 and a median of -$354000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 2302.06% in 2023, then slumped 358.39% in 2025.
- Over 2 years, Other Working Capital Changes stood at -$32000.0 in 2022, then surged by 156.25% to $18000.0 in 2023.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $18000.0, $5000.0, and $97000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 18,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 97,000.00 |
| Mar 31, 2023 | 97,000.00 |
| Mar 31, 2023 | 97,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Jun 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -31,000.00 |
| Mar 31, 2022 | -33,000.00 |
| Mar 31, 2022 | -33,000.00 |
| Mar 31, 2022 | -33,000.00 |